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Analysis of the genome of the leprosy bacillus uncovers
evidence of extensive deletion and inactivation of
genes. Secluded in a specialised niche, it has discarded
much of its genetic heritage, though retaining just
enough to be a major human pathogen.
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“I forbid you to leave your house unless dressed in your recognis-
able garb and also shod. I forbid you to enter any tavern; and if
you wish for wine, whether you buy it or it is given to you, have it
funnelled into your keg.” From the Mass of Separation in
Martene’s De Antiquis Ecclesiae Ritibus.
When leprosy was rife in medieval Europe, unfortunate
sufferers were relieved of their worldly goods and con-
demned to an isolated existence outwith the bounds of
conventional society. The description of the complete
genome sequence reported by Stewart Cole and his
colleagues [1] suggests that, in an evolutionary irony, the
leprosy bacillus has itself been subject to a similar fate.
Mycobacterium leprae was initially identified in lesions from
leprosy patients by Armauer Hansen in 1873, but failure to
culture the organism or to transfer disease to experimental
animals soon left research on the leprosy bacillus a poor
second to Robert Koch’s pursuit of its more tractable cousin,
Mycobacterium tuberculosis. Progress was made by Charles
Shephard in the 1960s, with the demonstration of a limited
infection of M. leprae in mouse footpads, and then by iden-
tification of the nine-banded armadillo as a suitable host
for systemic infection in the 1970s. However, M. leprae has
continued to elude attempts at laboratory culture, and it
was the armadillo that provided the raw material for the
sequencing project.
Just enough for a lazy bacterium
Genome analysis was initiated in the 1980s, but once again
M. leprae was relegated behind M. tuberculosis, for which
the sequence was published in 1998 [2]. In fact, this had
advantages in that the most striking features of the leprosy
genome emerge from its comparison with the ‘proper’
mycobacterial genome of M. tuberculosis. M. leprae provides
a dramatic example of reductive evolution. The  M. leprae
genome is significantly smaller than that of M. tuberculosis
— 3.3 million base pairs as compared to 4.4 million — and
of the remaining genetic material, half has been scrambled
into meaningless pseudogenes. The presumed scenario is
that M. leprae, having committed itself to a highly spe-
cialised niche in man (and the nine-banded armadillo),
found itself in an evolutionary backwater free from the
competitive pressures experienced by the majority of
microbes. Mutations occurring in asexual populations are
rarely reversed, driving a natural trend towards genomes
with an ever increasing burden of mostly deleterious
mutations. Each time the fittest organism carrying the
least mutations is lost from an isolated population — by
additional mutation, or by random events leading to extinc-
tion — Muller’s ratchet clicks round one notch and the
minimal load of mutation has irreversibly increased [3].
Genome decay is an occupational hazard for the obligate
intracellular pathogen [4].
What are the gene functions that M. leprae has lost? In
the context of understanding the biology of infection, it
would be of particular interest to identify examples where
M. leprae has come to rely on the host genome to supply
essential functions and nutrients. For the most part,
however, gene loss has affected flexibility rather than
essentiality. M. tuberculosis has multiple enzymes suitable
for the central metabolic activity of lipid degradation, for
example, whereas these have been stripped to a bare
Figure 1
Just enough citrate synthase in M. leprae. M. tuberculosis has three
genes encoding citrate synthase homologues (shown as red boxes).
Alignment with the corresponding regions of the M. leprae genome
shows that only one of the genes — gltA2 — remains intact. The citA-
like gene (green) in M. leprae has multiple stop codons and frame-
shifts; open reading frame ML0959 (blue) contains only a short stretch
of sequence matching gltA1.
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minimum in M. leprae. The pathways for biosynthesis of
amino acids and other major metabolites appear for the
most part to be intact. Cole and colleagues [1] have referred
to this as metabolic streamlining, or the ‘just enough’
strategy; ‘luxury’ genes with duplicative functions have
decayed, but an essential core set of genes has been main-
tained (Figure 1).
An exception to this simple streamlining may be in NAD-
dependent energy metabolism. Deletion of most of the
NADH oxidase operon is likely to have significantly
damaged the ability of M. leprae to generate energy. It may
be that this defect is compensated by reliance on the host
to funnel energy into the keg of M. leprae in some way,
but this central energetic glitch almost certainly makes an
important contribution to the reluctant growth of the
leprosy bacillus. Loss of genes involved in recombination
and repair of DNA may deal a final blow to hopes of an
evolutionary reprieve for M. leprae by means of horizontal
gene transfer (Figure 2).
Elimination of leprosy
It is likely that M. leprae is progressing down a ratchet of
self-immolation, destined for evolutionary extinction. Is it
safe to sit back and watch this happen? There are two
strong arguments against complacency. Firstly, leprosy
remains an important global health problem. The World
Health Organisation estimated that there were 740,000 new
cases of leprosy in 1999, and 750,000 cases in the year 2000
[5]. Implementation of effective multidrug therapy for
leprosy has resulted in a dramatic reduction from an esti-
mated prevalence of 10–15 million in the 1980s, but there
is no indication of a decline in the incidence of new cases.
Epidemiological calculations suggest that leprosy will fail
to be self-sustaining when the prevalence falls below 1 per
10,000 of the population. Although we are close to this
target on a global level — the current prevalence is 1.25
per 10,000 — clustering of cases in particular regions and
uncertain transmission dynamics have the potential to
upset expectations.
Information from the genome provides important leads in
terms of improved understanding of leprosy transmission.
Strain typing — based on genetic differences amongst
mycobacterial isolates — may help in deciding whether
new cases of leprosy are due to recent transmission or are
rather a delayed reflection of transmission patterns prior to
implementation of multidrug therapy. Typing systems
have not yet been developed for M. leprae, though experi-
ence with M. tuberculosis and the recent description of
variable tandem repeat elements [6,7] suggest that the
genome will provide productive grounds for exploration in
this regard.
In an evolutionary context, it will also be of interest to
apply typing systems to historical samples. It is possible to
amplify short sequences of DNA from leprosy lesions in
ancient human bones [8,9]; can we determine whether the
leprosy bacillus in contemporary India has changed from
that in early medieval Europe? In addition to analysis of
mycobacterial isolates, it should also be possible to monitor
leprosy transmission by screening of human immune
responses. The leprosy genome contains a set of genes
that are absent from M. tuberculosis and could provide the
basis for species-specific immunological reagents. Detec-
tion of cell mediated immune recognition of selected pep-
tides in blood-based or skin test assays may provide a
reliable indication of the number of individuals exposed to
Figure 2
Suicidal tendencies in M. leprae. Genes
involved in DNA replication, recombination and
repair in M. tuberculosis and M. leprae, with
those missing or mutated in M. leprae
indicated as white boxes. Many of the genes
associated with DNA repair and recombination
have been lost entirely or exist as
pseudogenes in M. leprae. The recBCD genes
that encode the exonuclease V complex are all
absent, suggesting that recombination in
M. leprae occurs at a very low rate, possibly
using RecF. A number of proteins involved in
proof reading are also missing; the alpha and
epsilon subunits of DNA polymerase III exist
only as pseudogenes, as does the nucleoside
triphosphatase MuT, which is part of the
methylation-directed error correction system.
Derived from a gene that encoded an enzyme
involved in repairing alkylation damage, alkA is
a pseudogene, and genes for several members
of the family of DNA-damage inducible
proteins are either missing (dinG and dinF) or
pseudogenes (dinX and dinP). This suggests
that Muller’s ratchet has turned so far that the
ability of M. leprae to maintain the integrity of
its genome is now compromised, and that
extinction is just a matter of time.
dnaE2 dnaQ
recB recC recD
recX dinF dinG dinP dinX helZ
uvrD2
xthA alkA
mutT1 mutT2 mutT3 ligB ligC nei
radA mrr ihr
dnaA dnaB dnaE1 dnaG dnaN dnaZX
recA recF recG recN recR
helY polA
uvrA uvrB uvrC uvrD gyrA gyrB priA
ruvA ruvB ruvC fpg mfd ung
mutY ligA
ogt topA nth ssb tagA
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M. leprae within a community in advance of the onset of
actual clinical cases [10].
Lessons from leprosy
A second argument against a complacent attitude to leprosy
research is based on the premise that study of the disease
has much to offer in terms of our understanding both of
host–pathogen interactions and of more general human
biology. In particular, of course, M. leprae provides impor-
tant comparative lessons for tuberculosis. Although M. tuber-
culosis isolates are strikingly homogenous at the level of
primary nucleotide sequence [11], insertion and deletion
events provide evidence of significant genome plasticity.
There is considerable interest in the possibility that these
changes impact on clinical and epidemiological manifesta-
tions of tuberculosis, with the number of deletions in a
particular isolate seen to correlate with ability to cause cav-
itary disease, for example [12]. Viewing these events in the
context of the more extreme genetic changes in M. leprae
will help in understanding their mechanisms and biologi-
cal relevance in M. tuberculosis.
A remarkable feature of leprosy is its occurrence in a
spectrum of clinical manifestations, ranging from the multi-
bacillary lepromatous form to paucibacillary tuberculoid
disease in different individuals. Leprosy represents a clas-
sical example of the way in which the host response influ-
ences the course of infection and provides an exciting
challenge to understanding the genetics of disease suscep-
tibility. Studies to date suggest that the different disease
phenotypes result from variations at multiple genetic loci,
each making some small contribution to susceptibility,
rather than any single dominant determinant [13,14].
The difference between the two polar forms of the
disease is strikingly reflected in the immune response.
Lepromatous leprosy is characterised by a high antibody
response and by an absence of a T-cell response to
M. leprae antigens, with the reverse being the case in the
tuberculoid form. This is the classic picture of the
Th1/Th2 paradigm — where Th1 and Th2 are the two
types of helper T cell — and leprosy provides an opportu-
nity to probe the extremes of human immunology [15,16].
Pathology in all forms of leprosy ultimately relates to
nerve damage associated with the ability of M. leprae to
enter the Schwann cells that provide a protective sheath
around axons in the peripheral nervous system. Consider-
able progress has been made in identifying the molecular
mechanisms underlying the Schwann cell predilection of
M. leprae, providing insights of general relevance to peri-
pheral neuropathy [17].
M. leprae represents an extremity of evolution. Genome
analysis reveals it to be honed to a minimum, but it has
clearly retained just enough to be able to cause considerable
mishap and mayhem to our immune response and nervous
system. We ignore leprosy and the lessons of leprosy at our
peril.
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